Use access key #2 to skip to page content.
$2.10 0.00 (0.00%)
5/2/2008 4:00 PM

Renovis, Inc. (RNVS)

CAPS Rating:
**

The Company is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases.

View All Commentary (RNVS)

Recs

0

Avatar Lifeguru (66.82) Submitted: 5/16/07 9:01 PM : Underperform Start Price: $3.42 RNVS Score: 22.45

see malstryx

Report this Post Replies: 0 | Reply

Featured Broker Partners